Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Munster-based intensive chemotherapy

Journal of Clinical Oncology

Volumn 13, Issue 10, 1995, Pages 2497-2502

  Conter, V ^a   Arico, M ^a   Valsecchi, M G ^a   Rizzari, C ^a   Testi, A M ^a   Messina, C ^a   Mori, P G ^a   Miniero, R ^a   Colella, R ^a   Basso, G ^a   Rondelli, R ^a   Pession, A ^a   Masera, G ^a  

^a SAN GERARDO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; HUMAN; INTRATHECAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SKULL IRRADIATION;

EID: 0029080839     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1995.13.10.2497     Document Type: Article

References (0)